Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood–Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation

[Image: see text] Despite limited evidence for infection of SARS-CoV-2 in the central nervous system, cognitive impairment is a common complication reported in “recovered” COVID-19 patients. Identification of the origins of these neurological impairments is essential to inform therapeutic designs ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Wesley, Stout, Angela, Yanchik-Slade, Francine, Li, Herman, Terrando, Niccolò, Nilsson, Bradley L., Gelbard, Harris A., Krauss, Todd D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463222/
https://www.ncbi.nlm.nih.gov/pubmed/37649833
http://dx.doi.org/10.1021/acsanm.3c02719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463222/
https://www.ncbi.nlm.nih.gov/pubmed/37649833
http://dx.doi.org/10.1021/acsanm.3c02719

Ejemplares similares